The Clinical, Epidemiological and Treatment Characteristics of Head and Neck Cancer Patients

Launched by UNIVERSITY OF PECS · Mar 31, 2022

Keywords

ClinConnect Summary

This clinical trial is studying patients with head and neck cancer to better understand their experiences and outcomes. Researchers want to gather important information about the characteristics of these patients, including their lifestyle, health history, and the time it takes for them to get diagnosed and start treatment. They hope that by learning more about these factors, they can find ways to improve the care and survival rates for people with head and neck cancer in Baranya County.

To be eligible for this study, participants need to be at least 18 years old and have been diagnosed with head and neck cancer, specifically a type called squamous cell carcinoma. This must be their first cancer diagnosis. Those who have had previous cancers will not be included. If you join the study, you can expect to share information about your health and lifestyle, and your progress will be monitored over several years to see how well treatments are working. This research aims to identify ways to enhance the treatment and outcomes for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients 18 years or over presenting with head and neck cancer (with morphology of squamocellular carcinoma), who are subsequently given one of the following ICD-10 codes: Malignant neoplasms of lip, oral cavity and pharynx (C00-C14), Malignant neoplasm of larynx (C32) and for whom this is their first cancer.
• Exclusion Criteria:
• • Patients who do not meet the inclusion criteria and patients who meet the inclusion criteria but for whom this is a second or recurrent cancer (they already have an "ICD-C" code) are excluded from the study